CVS · CVS HEALTH Corp · Documents
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
CVS Health expects its separation into two independent, publicly traded companies to be completed in the first half of 2028, raised 2026 adjusted EPS guidance to at least $8.20 and forecast at least $8.65 for 2027.
CVS Health plans to separate into CVS Health and CVS Pharmacy in the first half of 2028; nine-month operating income increased $10.4 billion, or 408.2%, as prior-year charges did not recur.
CVS Health intends to separate into a healthcare solutions company and CVS Pharmacy in the first half of 2028; David Joyner and Prem Shah will lead the respective companies as CEOs.
CVS Health reported third-quarter revenue of $108.4 billion, up 5.4%, and Adjusted EPS of $2.09, while raising full-year 2026 GAAP EPS guidance to at least $6.98, Adjusted EPS to at least $8.20 and cash flow to at least $15.5 billion.